CoChat

Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival

Open access

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Background: Proneurotrophins and mature neurotrophins elicit opposite effects via the p75 neurotrophin receptor (p75 NTR) and Trk tyrosine kinase receptors, respectively; however the molecular roles of proneurotrophins in the CNS are not fully understood. Results: Based on two rare single nucleotide polymorphisms (SNPs) of the human brain-derived neurotrophic factor (BDNF)gene, we generated R125M-, R127L- and R125M/R127L-BDNF, which have amino acid substitution(s) near the cleavage site between the pro- and mature-domain of BDNF. Western blot analyses demonstrated that these BDNF variants are poorly cleaved and result in the predominant secretion of proBDNF. Using these cleavage-resistant proBDNF (CR-proBDNF) variants, the molecular and cellular roles of proBDNF on the CNS neurons were examined. First, CR-proBDNF showed normal intracellular distribution and secretion in cultured hippocampal neurons, suggesting that inhibition of proBDNF cleavage does not affect intracellular transportation and secretion of BDNF. Second, we purified recombinant CR-proBDNF and tested its biological effects using cultured CNS neurons. Treatment with CR-proBDNF elicited apoptosis of cultured cerebellar granule neurons (CGNs), while treatment with mature BDNF (matBDNF) promoted cell survival. Third, we examined the effects of CR-proBDNF on neuronal morphology using more than 2-week cultures of basal forebrain cholinergic neurons (BFCNs) and hippocampal neurons. Interestingly, in marked contrast to the action of matBDNF, which increased the number of cholinergic fibers and hippocampal dendritic spines, CR-proBDNF dramatically reduced the number of cholinergic fibers and hippocampal dendritic spines, without affecting the survival of these neurons. Conclusion: These results suggest that proBDNF has distinct functions in different populations of CNS neurons and might be responsible for specific physiological cellular processes in the brain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1756-6606-2-27

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 BDNF polymorphic substitutions inhibit the conversion of proBDNF to matBDNF and lead to predominant secretion of proBDNF in CNS neurons. (A) Schematic of human BDNF protein. Amino acid substitutions near the cleavage site in rare SNP variants are represented by single-letter symbols. The amino acid substitutions caused by the SNPs are depicted by white symbols. (B) Bioinformatic prediction of changes in the secondary structure of proBDNF SNPs variants using PONDR. M, L and ML depict the amino acid substitution of R125M, R127L and R125M/R127L, respectively. The disordered regions (PONDR score > 0.5) of wild-type BDNF (aa 25–103 and 120–140) is highlighted by bold lines. (C) Inhibition of the intracellular cleavage of SNP variants in cultured hippocampal neurons. The cultures were infected with Sindbis viruses expressing wild-type (RR), R125M (M), R127L (L), and R125M/R127L (ML) constructs for 12 h and 3 days later processed for Western blot analysis using anti-BDNF (IB: BDNF) and anti-Myc antibodies (IB: Myc). Doublet bands of 29- and 32-kDa were detected with the monoclonal anti-proBDNF antibody (IB: proBDNF), whereas an additional band of 14-kDa (matBDNF) was detected using an antibody against the mature domain (IB: BDNF). The levels of bicistronically expressed GFP, which correlated with the viral infection levels, were similar in all cultures. Note that proBDNF bands were predominant in the lysates of cells expressing the M, L, and ML constructs, while matBDNF expression was residual. In C and F, 1 ng recombinant matBDNF and proBDNF (R125M/R127L-BDNF) were used as positive controls. (D) The ratio of proBDNF to matBDNF was quantified by densitometric analysis on BDNF, and proBDNF bands. **P < 0.01 (Student's t-test) when compared with matBDNF (matBDNFRR + proBDNFRR = 100% as control). n = 3 independent experiments. (E) The entire amount of BDNF was quantified by densitometric analysis on matBDNF, proBDNF, and GFP bands. *P < 0.05 (t-test) when compared with RR (100% as control). n = 3 independent experiments. (F) Secretion of poorly cleaved proBDNF. Cultured cerebral cortical neurons were incubated with Sindbis viruses for 12 h and maintained in serum-containing medium for 3 days. Supernatants were collected and immunoprecipitated using anti-Myc antibody-conjugated agarose beads, followed by Western blot analysis using rabbit antibody against the mature domain (IB: BDNF) and mouse antibody recognizing the prodomain (IB: proBDNF). Cell lysates were blotted with anti-GFP antibody to normalize viral infection (IB: GFP).
Figure 1 BDNF polymorphic substitutions inhibit the conversion of proBDNF to matBDNF and lead to predominant secretion of proBDNF in CNS neurons. (A) Schematic of human BDNF protein. Amino acid substitutions near the cleavage site in rare SNP variants are represented by single-letter symbols. The amino acid substitutions caused by the SNPs are depicted by white symbols. (B) Bioinformatic prediction of changes in the secondary structure of proBDNF SNPs variants using PONDR. M, L and ML depict the amino acid substitution of R125M, R127L and R125M/R127L, respectively. The disordered regions (PONDR score > 0.5) of wild-type BDNF (aa 25–103 and 120–140) is highlighted by bold lines. (C) Inhibition of the intracellular cleavage of SNP variants in cultured hippocampal neurons. The cultures were infected with Sindbis viruses expressing wild-type (RR), R125M (M), R127L (L), and R125M/R127L (ML) constructs for 12 h and 3 days later processed for Western blot analysis using anti-BDNF (IB: BDNF) and anti-Myc antibodies (IB: Myc). Doublet bands of 29- and 32-kDa were detected with the monoclonal anti-proBDNF antibody (IB: proBDNF), whereas an additional band of 14-kDa (matBDNF) was detected using an antibody against the mature domain (IB: BDNF). The levels of bicistronically expressed GFP, which correlated with the viral infection levels, were similar in all cultures. Note that proBDNF bands were predominant in the lysates of cells expressing the M, L, and ML constructs, while matBDNF expression was residual. In C and F, 1 ng recombinant matBDNF and proBDNF (R125M/R127L-BDNF) were used as positive controls. (D) The ratio of proBDNF to matBDNF was quantified by densitometric analysis on BDNF, and proBDNF bands. **P < 0.01 (Student's t-test) when compared with matBDNF (matBDNFRR + proBDNFRR = 100% as control). n = 3 independent experiments. (E) The entire amount of BDNF was quantified by densitometric analysis on matBDNF, proBDNF, and GFP bands. *P < 0.05 (t-test) when compared with RR (100% as control). n = 3 independent experiments. (F) Secretion of poorly cleaved proBDNF. Cultured cerebral cortical neurons were incubated with Sindbis viruses for 12 h and maintained in serum-containing medium for 3 days. Supernatants were collected and immunoprecipitated using anti-Myc antibody-conjugated agarose beads, followed by Western blot analysis using rabbit antibody against the mature domain (IB: BDNF) and mouse antibody recognizing the prodomain (IB: proBDNF). Cell lysates were blotted with anti-GFP antibody to normalize viral infection (IB: GFP).CC BY · PubMed Central
Figure 2 Intracellular proteolytic cleavage of proBDNF is not a crucial step for intracellular transportation and secretion of BDNF in hippocampal neurons. (A) Distribution of GFP-tagged wild-type BDNF (BDNF-GFP) and cleavage-resistant (CR)-proBDNF (R125M/R127L-BDNF-GFP) in the cell body and processes. Cultured neurons were subjected to Sindbis viruses expressing the indicated constructs for 3 h. Three days later, the neurons were fixed for imaging of GFP fluorescence using confocal microscope. Representative low-magnification (upper) and high-magnification images of the cell body (middle) and neuronal processes (bottom) are shown. (B-C) The infected cells were immunostained with the indicated antibodies for confocal imaging. Note that CR-proBDNF-GFP greatly co-localized with TGN38 (B) and SgII (C), similarly to wild-type BDNF-GFP (arrows). Scale bar in all images, 10 μm. (D) Expression of wild-type proBDNF-Myc or CR-proBDNF-Myc. Hippocampal neurons were introduced with constructs encoding GFP and wild-type BDNF-Myc or CR-proBDNF-Myc using Sindbis virus expression system. Three-days after a brief (3 h) infection, cells were double-stained using anti-Myc and anti-proBDNF antibodies. BDNF-Myc signals largely co-localized with proBDNF signals (arrows) indicating that proBDNF is the predominant intracellular isoform. Scale bar, 5 μm.
Figure 2 Intracellular proteolytic cleavage of proBDNF is not a crucial step for intracellular transportation and secretion of BDNF in hippocampal neurons. (A) Distribution of GFP-tagged wild-type BDNF (BDNF-GFP) and cleavage-resistant (CR)-proBDNF (R125M/R127L-BDNF-GFP) in the cell body and processes. Cultured neurons were subjected to Sindbis viruses expressing the indicated constructs for 3 h. Three days later, the neurons were fixed for imaging of GFP fluorescence using confocal microscope. Representative low-magnification (upper) and high-magnification images of the cell body (middle) and neuronal processes (bottom) are shown. (B-C) The infected cells were immunostained with the indicated antibodies for confocal imaging. Note that CR-proBDNF-GFP greatly co-localized with TGN38 (B) and SgII (C), similarly to wild-type BDNF-GFP (arrows). Scale bar in all images, 10 μm. (D) Expression of wild-type proBDNF-Myc or CR-proBDNF-Myc. Hippocampal neurons were introduced with constructs encoding GFP and wild-type BDNF-Myc or CR-proBDNF-Myc using Sindbis virus expression system. Three-days after a brief (3 h) infection, cells were double-stained using anti-Myc and anti-proBDNF antibodies. BDNF-Myc signals largely co-localized with proBDNF signals (arrows) indicating that proBDNF is the predominant intracellular isoform. Scale bar, 5 μm.CC BY · PubMed Central
Figure 3 Recombinant CR-proBDNF induces apoptosis of cerebellar granule neurons cultured in low K+-containing medium. (A) Preparation of recombinant CR-proBDNF (R125M/R127L-BDNF: proBDNFML) using the Baculovirus or E. coli expression systems. Protein products were analyzed by silver staining (left) and Western blotting using rabbit antibody against BDNF prodomain. (B-C) Opposite actions of CR-proBDNF and matBDNF revealed by apoptosis assay. After 4 days of culture in HK medium, CGNs were treated with E. coli-derived CR-proBDNF or matBDNF in LK medium. Cell death was assessed using DAPI staining 48 h after treatment with the indicated drug in LK medium. (B) Arrows and arrowheads indicate representative living and dead cells, respectively. Scale bar, 50 μm. (C) For quantification of cell death, 300–400 cells were counted in four independent fields per coverslip. (D) Dose-dependent test of pro-apoptotic activity of CR-proBDNF. Cell death was assessed using DAPI staining 48 h after treatment with CR-proBDNF in LK medium. DAPI data were expressed as the percentage of mock cultures. In the cell death assay (C-D), n = 4 independent culture dishes. ANOVA followed by post-hoc analysis, *P < 0.05; **P < 0.01. Results were replicated in at least three independent experiments.
Figure 3 Recombinant CR-proBDNF induces apoptosis of cerebellar granule neurons cultured in low K+-containing medium. (A) Preparation of recombinant CR-proBDNF (R125M/R127L-BDNF: proBDNFML) using the Baculovirus or E. coli expression systems. Protein products were analyzed by silver staining (left) and Western blotting using rabbit antibody against BDNF prodomain. (B-C) Opposite actions of CR-proBDNF and matBDNF revealed by apoptosis assay. After 4 days of culture in HK medium, CGNs were treated with E. coli-derived CR-proBDNF or matBDNF in LK medium. Cell death was assessed using DAPI staining 48 h after treatment with the indicated drug in LK medium. (B) Arrows and arrowheads indicate representative living and dead cells, respectively. Scale bar, 50 μm. (C) For quantification of cell death, 300–400 cells were counted in four independent fields per coverslip. (D) Dose-dependent test of pro-apoptotic activity of CR-proBDNF. Cell death was assessed using DAPI staining 48 h after treatment with CR-proBDNF in LK medium. DAPI data were expressed as the percentage of mock cultures. In the cell death assay (C-D), n = 4 independent culture dishes. ANOVA followed by post-hoc analysis, *P < 0.05; **P < 0.01. Results were replicated in at least three independent experiments.CC BY · PubMed Central
Figure 4 Neurite growth of basal forebrain cholinergic neurons is inhibited by CR-proBDNF, but elicited by matBDNF. BFCNs were cultured in serum-containig (A-E) or serum-free (F) medium for 2 weeks and treated with 100 ng/ml CR-proBDNF or matBDNF in the same medium condition for 2 days. Histochemistry and quantitation of AChE-positve neurites were done as described in Methods. (A) BFCNs were double-stained using AChE histochemistry and Hoechst 33258 (arrows). (B) The survival rate of BFCNs (%) = 100 × [living cells]/([living cells] + [dead cells]). Data were normalized to mock cultures (100% as control). n = 159 (Mock), 151 (matBDNF), and 149 (CR-proBDNF) from three independent coverslips. Results were replicated in three independent experiments. (C) Low- and high-magnification images of AChE-stained BFCNs. (D) The number of neurites extending outwards from the cell body shown in C. n = 38 (Mock), 37 (matBDNF), and 40 (CR-proBDNF) cells from three independent coverslips. (E) Neurite complexity as revealed by Sholl analysis. n = 30 (Mock), 30 (matBDNF), and 30 (CR-proBDNF) cells from three independent coverslips. In multi-bar graphs, ANOVA followed by post-hoc analysis was used. **P < 0.01. Results were replicated in at least three independent experiments. (F) The opposing effects of matBDNF and CR-proBDNF on neurite fiber density were confirmed by a distinct quantitative method. The maximal threshold of AChE-positive cholinergic fiber intensity was defined as 70% above the background. The total intensity of the fibers was determined in an optical field and was divided by the number of AChE-positive neurons in the same field. Data were collected from four independent fields in a single chamber. t-test, **P < 0.01, compared to Mock (100% as control); n = 6 independent culture dishes. Scale bar, 5 μm (A and C). (G) Effect of CR-proBDNF on neurite density of BFCNs in serum-free condition and a dose-dependency test of CR-proBDNF. Cell survival (left) and the neurite number of BFCNs (right) were determined. Note that proBDNF negatively regulates the neurite density of BFCNs in serum-free conditions and at subnanomoler concentration. n = 3 independent coverslips. t-test, **P < 0.01, significantly different from Mock.
Figure 4 Neurite growth of basal forebrain cholinergic neurons is inhibited by CR-proBDNF, but elicited by matBDNF. BFCNs were cultured in serum-containig (A-E) or serum-free (F) medium for 2 weeks and treated with 100 ng/ml CR-proBDNF or matBDNF in the same medium condition for 2 days. Histochemistry and quantitation of AChE-positve neurites were done as described in Methods. (A) BFCNs were double-stained using AChE histochemistry and Hoechst 33258 (arrows). (B) The survival rate of BFCNs (%) = 100 × [living cells]/([living cells] + [dead cells]). Data were normalized to mock cultures (100% as control). n = 159 (Mock), 151 (matBDNF), and 149 (CR-proBDNF) from three independent coverslips. Results were replicated in three independent experiments. (C) Low- and high-magnification images of AChE-stained BFCNs. (D) The number of neurites extending outwards from the cell body shown in C. n = 38 (Mock), 37 (matBDNF), and 40 (CR-proBDNF) cells from three independent coverslips. (E) Neurite complexity as revealed by Sholl analysis. n = 30 (Mock), 30 (matBDNF), and 30 (CR-proBDNF) cells from three independent coverslips. In multi-bar graphs, ANOVA followed by post-hoc analysis was used. **P < 0.01. Results were replicated in at least three independent experiments. (F) The opposing effects of matBDNF and CR-proBDNF on neurite fiber density were confirmed by a distinct quantitative method. The maximal threshold of AChE-positive cholinergic fiber intensity was defined as 70% above the background. The total intensity of the fibers was determined in an optical field and was divided by the number of AChE-positive neurons in the same field. Data were collected from four independent fields in a single chamber. t-test, **P < 0.01, compared to Mock (100% as control); n = 6 independent culture dishes. Scale bar, 5 μm (A and C). (G) Effect of CR-proBDNF on neurite density of BFCNs in serum-free condition and a dose-dependency test of CR-proBDNF. Cell survival (left) and the neurite number of BFCNs (right) were determined. Note that proBDNF negatively regulates the neurite density of BFCNs in serum-free conditions and at subnanomoler concentration. n = 3 independent coverslips. t-test, **P < 0.01, significantly different from Mock.CC BY · PubMed Central
Figure 5 proBDNF reduces dendritic spine density in hippocampal neurons. Cultured neurons were maintained for 3–4 weeks and treated with the indicated reagents (50 ng/ml) for 2 (A, B, and D) or 3 days (C). In A and B, neurons were cultured in serum-containing medium. (A) CR-proBDNF reduced the density of DiI-labeled spines. Representative images of DiI-labeled neurons treated with the indicated reagents for 2 days (left). Summary of spine density (middle) and length (right). Data were collected from 52 (Mock), 59 (matBDNF), and 38 (CR-proBDNF) independent cells (non-parametric test, *P < 0.05, compared to Mock). Note that matBDNF increased spine density, while proBDNF reduced spine density (arrows and arrowheads). (B) proBDNF promoted the shrinkage of phalloidin-labeled spines and p75NTR was involved in the proBDNF action. Application of a functionally blocking antibody against p75NTR, AB1554 was performed and fixed neurons were stained with an anti-MAP2 antibody and FITC-labeled phalloidin. Representative images of the double-stained neurons (left) and a quantitative analysis of phalloidin-labeled spiny structures (right) are shown, n = 30–40 independent cells from three independent coverslips. t-test, *P < 0.05, **P < 0.01, compared to Mock (100% as control). (C) CR-proBDNF decreases spine density in low-density hippocampal neurons cultured in serum-free medium. The cultures were incubated with CR-proBDNF in serum-free medium for 2 days and double-stained with an anti-MAP2 antibody and FITC-labeled phalloidin. n = 24–32 cells from three independent coverslips. t-test, *P < 0.05, **P < 0.01, compared to Mock. (D) CR-proBDNF decreased spine density in hippocampal slices. Representative images of DiI-labeled neurons at low and high magnification are shown (left). A decrease in spine density was observed in CR-proBDNF-treated slices (arrow heads). Quantification of spine density (right). Data were collected from 7 (Mock) and 6 (CR-proBDNF) independent slices. Note that CR-proBDNF-treated slices showed a decrease in spine density when compared with matBDNF. t-test, *P < 0.05. Scale bar, 10 μm (A, B, and D).
Figure 5 proBDNF reduces dendritic spine density in hippocampal neurons. Cultured neurons were maintained for 3–4 weeks and treated with the indicated reagents (50 ng/ml) for 2 (A, B, and D) or 3 days (C). In A and B, neurons were cultured in serum-containing medium. (A) CR-proBDNF reduced the density of DiI-labeled spines. Representative images of DiI-labeled neurons treated with the indicated reagents for 2 days (left). Summary of spine density (middle) and length (right). Data were collected from 52 (Mock), 59 (matBDNF), and 38 (CR-proBDNF) independent cells (non-parametric test, *P < 0.05, compared to Mock). Note that matBDNF increased spine density, while proBDNF reduced spine density (arrows and arrowheads). (B) proBDNF promoted the shrinkage of phalloidin-labeled spines and p75NTR was involved in the proBDNF action. Application of a functionally blocking antibody against p75NTR, AB1554 was performed and fixed neurons were stained with an anti-MAP2 antibody and FITC-labeled phalloidin. Representative images of the double-stained neurons (left) and a quantitative analysis of phalloidin-labeled spiny structures (right) are shown, n = 30–40 independent cells from three independent coverslips. t-test, *P < 0.05, **P < 0.01, compared to Mock (100% as control). (C) CR-proBDNF decreases spine density in low-density hippocampal neurons cultured in serum-free medium. The cultures were incubated with CR-proBDNF in serum-free medium for 2 days and double-stained with an anti-MAP2 antibody and FITC-labeled phalloidin. n = 24–32 cells from three independent coverslips. t-test, *P < 0.05, **P < 0.01, compared to Mock. (D) CR-proBDNF decreased spine density in hippocampal slices. Representative images of DiI-labeled neurons at low and high magnification are shown (left). A decrease in spine density was observed in CR-proBDNF-treated slices (arrow heads). Quantification of spine density (right). Data were collected from 7 (Mock) and 6 (CR-proBDNF) independent slices. Note that CR-proBDNF-treated slices showed a decrease in spine density when compared with matBDNF. t-test, *P < 0.05. Scale bar, 10 μm (A, B, and D).CC BY · PubMed Central
Figure 6 CR-proBDNF attenuates amplitude of functional synaptic transmission in cultured hippocampal neurons. Cells were cultured as described in Fig. 5A and treated with the indicated reagents for 3 days. A patch-clamp technique in the whole-cell configuration was used to record mEPSCs from pyramidal-shaped neurons and all data were statistically evaluated. (A) Representative mEPSCs. (B) Amplitude (left) and frequency (right) of mEPSCs. Note that proBDNF significantly decreased the amplitude, but not the frequency, of mEPSCs. Data were collected from 27–31 independent cells (non-parametric test, *P < 0.05, significantly different from Mock).
Figure 6 CR-proBDNF attenuates amplitude of functional synaptic transmission in cultured hippocampal neurons. Cells were cultured as described in Fig. 5A and treated with the indicated reagents for 3 days. A patch-clamp technique in the whole-cell configuration was used to record mEPSCs from pyramidal-shaped neurons and all data were statistically evaluated. (A) Representative mEPSCs. (B) Amplitude (left) and frequency (right) of mEPSCs. Note that proBDNF significantly decreased the amplitude, but not the frequency, of mEPSCs. Data were collected from 27–31 independent cells (non-parametric test, *P < 0.05, significantly different from Mock).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

See all 201

Metadata

Authors
Koshimizu, H., Kiyosue, K., Hara, T., Hazama, S., Suzuki, S., Uegaki, K., Nagappan, G., Zaitsev, E., Hirokawa, T., Tatsu, Y., Ogura, A., Lu, B., & Kojima, M.
Affiliations
  • National Institute of Advanced Industrial Science and Technology (JP)
  • Japan Science and Technology Agency (JP)
  • National Institutes of Health (US)
  • The University of Osaka (JP)
Corresponding author
Kojima, Masami
Venue
Molecular Brain
Published
2009-08-13
Volume
2
Issue
1
Pages
27-27
ISSN
1756-6606 (ISSN-L)
OpenAlex
W2096603652
Cited by
195
References
60
Citations by year
2026: 3 · 2025: 4 · 2024: 10 · 2023: 15 · 2022: 9 · 2021: 13 · 2020: 15 · 2019: 7 · 2018: 19 · 2017: 15 · 2016: 14 · 2015: 15 · 2014: 13 · 2013: 12 · 2012: 15
FWCI
4.30
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Brain (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Institute of Advanced Industrial Science and Technology
  • Ministry of Education, Culture, Sports, Science and Technology (40344171, CREST)
  • National Institutes of Health
  • Novartis Pharma
  • Japan Society for the Promotion of Science (CREST)
  • Japan Science and Technology Agency (CREST, 40344171)
  • National Institute of Mental Health
  • Core Research for Evolutional Science and Technology
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
proBDNF, brain-derived neurotrophic factor, single nucleotide polymorphisms, cerebellar granule cells, basal forebrain cholinergic neurons, hippocampal neurons, neurite outgrowth, dendritic spine formation, apoptosis, neuronal survival, neurotrophin signaling
MeSH terms
Animals, Antibody Specificity, Biological Transport, Cell Survival, Cells, Cultured, Central Nervous System, Culture Media, Hippocampus, Humans, Potassium, Protein Precursors, Protein Processing, Post-Translational, Recombinant Proteins, Neurites, Apoptosis, Protein Structure, Secondary, Brain-Derived Neurotrophic Factor, Computational Biology, Amino Acid Substitution, Polymorphism, Single Nucleotide, Intracellular Space, Mutant Proteins, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. https://app.cochat.ai/papers/10.1186/1756-6606-2-27
The paper
Koshimizu, H., Kiyosue, K., Hara, T., Hazama, S., Suzuki, S., Uegaki, K., Nagappan, G., Zaitsev, E., Hirokawa, T., Tatsu, Y., Ogura, A., Lu, B., & Kojima, M. (2009). Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. Molecular Brain. https://doi.org/10.1186/1756-6606-2-27

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.